Torrent Pharma to buy Glochem’s unitIllustrative image – not actual.

Ahmedabad-based Torrent Pharmaceuticals has entered into an agreement with Hyderabad-based Glochem Industries to acquire its active pharmaceutical ingredients (APIs) manufacturing unit in Vishakhapatnam, along with a few Drug Master Files (DMFs). No financial details were divulged, though it is estimated that the deal is between Rs 250 crore and Rs 300 crore.

The Vizag facility has four API manufacturing suites, a pilot plant and an R&D centre, and has approvals from USFDA and EUGMP.

The API unit approved by the USFDA and the European regulatory authorities is a multi-product facility, with a capacity to manufacture advance intermediates and active pharmaceutical ingredients (APIs).
 

← All latest storiesBack to top →